Glioblastoma Inhibition by Cell Surface Immunoglobulin Protein EWI-2, In Vitro and In Vivo
Authors:
- Alexander R. KazarovAKAlexander R. Kazarov
- Madeleine E. LemieuxMLMadeleine E. Lemieux
- Marc A. LafleurMLMarc A. Lafleur
- Santosh KesariSKSantosh Kesari
- Andrew L. KungAKAndrew L. Kung
- Martin E. HemlerMHMartin E. Hemler
Open Access
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: A preliminary feasibility studyGenomics, 2008
- Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCRJournal of Neuro-Oncology, 2008
- Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progressionJournal of Neuro-Oncology, 2007
- Olig2-Regulated Lineage-Restricted Pathway Controls Replication Competence in Neural Stem Cells and Malignant GliomaNeuron, 2007
- A cancer cell metalloprotease triad regulates the basement membrane transmigration programGenes & Development, 2006
- Profiling of the Tetraspanin Web of Human Colon Cancer CellsMolecular & Cellular Proteomics, 2006
- MRP-1/CD9 gene transduction downregulates Wnt signal pathwaysOncogene, 2004
- EWI-2 modulates lymphocyte integrin α4β1 functionsBlood, 2004
- EWI-2 regulates α3β1 integrin–dependent cell functions on laminin-5Journal of Cell Biology, 2003
- CD81 Regulates Neuron-Induced Astrocyte Cell-Cycle ExitMolecular and Cellular Neuroscience, 2001